Elanco Companion Animal Health has launched a novel prescription flea treatment for dogs which, according to the company, combines a rapid kill rate with convenient monthly oral administration.
Elanco says Comfortis Chewable Tablets for Dogs start to kill…
Elanco Companion Animal Health, maker of Comfortis chewable tablets for dogs, has launched a range of support materials to help educate pet owners on flea infestation and the healthcare issues associated with fleas and encourage enquiries about flea control…
Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.
The campaign revolves around some new research which shows that while nearly…
Elanco Companion Animal Health has launched of Dexdomitor 0.1 mg/ml, adding to its range of alpha-2 agonists and antagonists.
Produced and manufactured in partnership with Orion Corporation, Elanco says Dexdomitor 0.1 mg/ml contains all the properties…
Elanco Companion Animal Health has announced that Comfortis (spinosad) flavoured chewable flea control tablets have been licensed for cats.
In addition, the company has extended its range with the addition of two new sizes for toy dogs and smaller…
Elanco Companion Animal Health has launched Recuvyra 50mg/ml transdermal solution for dogs, the first transdermal fentanyl solution to be licensed for the control of postoperative pain associated with major orthopaedic and soft tissue surgery.
Recuvyra…
Elanco Companion Animal Health has launched Trifexis, an oral tablet to provide dogs with three-in-one protection against fleas, intestinal nematodes and heartworm.
Trifexis contains two active ingredients: spinosad, which is active against fleas, and…
Elanco has announced the results of a survey it conducted amongst European dermatology diplomates which found that nearly 90% of them consider Comfortis (spinosad) is the first choice of flea control for cats and dogs.
The research was conducted at the…
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a…
Elanco Companion Animal Health has launched a competition to encourage veterinary professionals to showcase the company's new range of practice support materials for the company's parasiticides, Comfortis and Trifexin.
To enter the competition…
Elanco Companion Animal Health, which makes Surolan and Surosolve, has launched a couple of short films to demonstrate to pet owners how to administer veterinary prescribed ear drops and clean their pet's ears.
Filmed with the University of Bristol…
Elanco Animal Health has launched Vulketan, a POM-V sterile topical gel developed to encourage the healing of equine wounds.
Vulketan contains ketanserin - a serotonin-S2 antagonist.2 Elanco says that although serotonin is more widely known as a neurotransmitter…
Elanco has announced that it has finalised its acquisition of Novartis Animal Health.
The acquisition, announced in April last year, follows Elanco's purchase of Lohmann Animal Health earlier in 2014. It swells Elanco's portfolio to nearly 300 brands…
Elanco Companion Animal Health has announced the results of research it carried out amongst veterinary nurses at BVNA to discover how they think owners feel about Comfortis, its oral flea control for cats and dogs.
The company conducted the research…
Elanco Animal Health, maker of Comfortis, Trifexis and Atopica, has launched ScratchTracker, a smartphone app designed to help dog owners with a simple way to monitor pruritus in their pet and share the results with their vet.
Elanco says ScratchTracker…
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now…
Elanco Animal Health has announced the launch of a Milbemax television advertising campaign to educate pet owners about the importance and ease of worming.
The 30-second advertisement will appear as pre-roll to video content on a number of websites from…
Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.
According to the company, compliance with daily ear drops has been shown to be poor, with up…
Elanco Animal Health has launched #PetMagicMoments, a social media campaign designed to drive engagement between veterinary practices and their clients and encourage customer footfall to veterinary practices.
As part of the #PetMagicMoments campaign, the…
For every 'Proud to support Dogs for Good' profile picture…
Sue, an RCVS and European…
In trials, Credelio killed more than 98% of ticks within 24 hours1, and more than 99% of fleas within 12 hours with all fleas…
The NSAID's new indication is in addition to its existing license for acute pain and…
Galliprant is a first in a class of drugs called piprants, or non-COX-inhibiting prostaglandin receptor antagonists (PRAs…
The Osurnia Ear Health Hub includes information about the treatment of canine otitis externa from dermatologists…